A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD

Saved in:
Bibliographic Details
Published in:Neurology Vol. 54; no. 8; pp. 1583 - 1588
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins 25-04-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1334977$$DView record in Pascal Francis
BookMark eNpFkM1LAzEQxYNUsK0evefgddd87SY5lvoJRT0oCh5CNpnQld1NSdZD_evdUsHTm8d7MzC_BZoNcQCELikpKaPs-v1pU1aiVCWtFD9Bc1qxuqg5-5ihOSFMFVxJdYYWOX8RMoVSz9HnCvff3dg6GEZIONnBx779AY9dHMYUu24ax9TaDseAE_TWQd96wNu9T9Ftu5gOzmbcxyGOW0h2t8chJvxyc45Og-0yXPzpEr3d3b6uH4rN8_3jerUpHKvFWDSW-ADAtXZBaqKa4HVNqsoLoEETzhVhXnllm0YoGYTwzjJgjksB3qnAl6g43nUp5pwgmF1qe5v2hhJzIGMmMqYSRpkDmal_dezvbHa2C9PTrs3_S5wLLSX_BZarZ5c
CODEN NEURAI
CitedBy_id crossref_primary_10_1016_j_baga_2013_09_001
crossref_primary_10_1006_exnr_2001_7681
crossref_primary_10_1002_mds_21409
crossref_primary_10_1586_14737175_2_6_819
crossref_primary_10_1586_14737175_2_3_403
crossref_primary_10_1097_01_wnf_0000240943_59617_4c
crossref_primary_10_1016_j_parkreldis_2008_06_005
crossref_primary_10_1016_S0014_2999_00_00939_0
crossref_primary_10_1016_j_pharmthera_2004_04_001
crossref_primary_10_1517_13543784_14_4_377
crossref_primary_10_1586_14737175_3_6_797
crossref_primary_10_1155_2013_196028
crossref_primary_10_2165_00002512_200320050_00006
crossref_primary_10_1002_mds_10642
crossref_primary_10_1212_WNL_56_4_455
crossref_primary_10_1016_j_neuint_2014_10_005
crossref_primary_10_2165_00128413_200012390_00024
crossref_primary_10_1016_j_mcn_2003_09_013
crossref_primary_10_1007_s11910_004_0052_2
crossref_primary_10_1002_ana_10488
crossref_primary_10_1124_jpet_117_247171
crossref_primary_10_1002_mds_22022
crossref_primary_10_1016_S0014_4886_03_00117_1
crossref_primary_10_2165_00002512_200118100_00001
crossref_primary_10_1002_mds_22645
crossref_primary_10_1016_j_pnpbp_2011_05_014
crossref_primary_10_1517_13543776_11_4_547
Cites_doi 10.1002/ana.410440726
10.1016/0165-0173(94)00014-G
10.1111/j.1528-1157.1996.tb01031.x
10.1002/ana.410390505
10.1016/S0920-1211(96)01005-4
10.1016/0022-3956(75)90026-6
10.1016/0166-2236(89)90074-X
10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D
10.1161/01.STR.29.11.2357
10.1523/JNEUROSCI.14-11-07192.1994
10.1007/BF02740748
10.1093/brain/114.5.2095
10.1002/mds.870110310
10.1126/science.2402638
10.1002/ana.410350605
10.1016/0920-1211(92)90086-9
10.1212/WNL.17.5.427
10.1016/0306-4522(89)90120-6
10.1002/ana.410280411
ContentType Journal Article
Copyright 2000 INIST-CNRS
Copyright_xml – notice: 2000 INIST-CNRS
CorporateAuthor Parkinson Study Group
CorporateAuthor_xml – name: Parkinson Study Group
DBID IQODW
AAYXX
CITATION
DOI 10.1212/WNL.54.8.1583
DatabaseName Pascal-Francis
CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
EndPage 1588
ExternalDocumentID 10_1212_WNL_54_8_1583
1334977
GroupedDBID ---
-~X
.55
.GJ
.XZ
.Z2
01R
08R
0R~
123
1CY
1J1
1KJ
29N
2WC
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
A9M
AAAXR
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAPBV
AAQKA
AAQQT
AARTV
AASOK
AASXQ
AAWTL
AAXQO
AAYEP
AAYOK
ABBLC
ABFLS
ABIVO
ABOCM
ACCJW
ACDDN
ACGFS
ACOAL
ACWRI
ADGIM
ADNKB
AE6
AEBDS
AENEX
AFDTB
AFFNX
AFUWQ
AGINI
AHVBC
AIJEX
AKULP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AWKKM
BOYCO
BQLVK
BYPQX
C45
CS3
DIWNM
DU5
E.X
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FA8
FW0
GQDEL
HZ~
H~9
IKYAY
IN~
IPNFZ
IQODW
J5H
JF7
KD2
KMI
L-C
L7B
N4W
N9A
NEJ
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHT
OHYEH
OJAPA
OL1
OLB
OLH
OLU
OLV
OLW
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RHF
RHI
RIG
RXW
SJN
TAE
TEORI
TWZ
UDS
V2I
VVN
W3M
WH7
WOQ
WOW
X7M
XJT
XOL
XSW
XXN
XYM
XYN
YBU
YCJ
YFH
YYP
ZA5
ZCG
ZGI
ZKB
ZXP
~9M
AAIQE
AASCR
AAYXX
ABJNI
ABVCZ
ACILI
ACLDA
ACXJB
ADGGA
AFEXH
AHOMT
AHQNM
AKWKN
AMNEI
AOHHW
CITATION
ERAAH
FCALG
RLZ
ID FETCH-LOGICAL-c264t-ba0dfee399cf7908bfd96055d4e1f9033802d8d8abb487f44dca2e2c374edc8f3
ISSN 0028-3878
IngestDate Fri Nov 22 00:43:27 EST 2024
Fri Nov 25 01:09:55 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Short term
Human
Nervous system diseases
Treatment efficiency
Multicenter study
Parkinson disease
Tolerance
Antiparkinson agent
Posology
Cerebral disorder
Chemotherapy
Remacemide
Treatment
Central nervous system disease
Placebo
Double blind study
Degenerative disease
Extrapyramidal syndrome
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c264t-ba0dfee399cf7908bfd96055d4e1f9033802d8d8abb487f44dca2e2c374edc8f3
PageCount 6
ParticipantIDs crossref_primary_10_1212_WNL_54_8_1583
pascalfrancis_primary_1334977
PublicationCentury 2000
PublicationDate 2000-04-25
PublicationDateYYYYMMDD 2000-04-25
PublicationDate_xml – month: 04
  year: 2000
  text: 2000-04-25
  day: 25
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
PublicationTitle Neurology
PublicationYear 2000
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_1_21_2
e_1_3_1_22_2
e_1_3_1_8_2
e_1_3_1_13_2
e_1_3_1_7_2
e_1_3_1_12_2
e_1_3_1_11_2
e_1_3_1_9_2
e_1_3_1_10_2
e_1_3_1_20_2
e_1_3_1_4_2
e_1_3_1_17_2
e_1_3_1_3_2
e_1_3_1_16_2
e_1_3_1_6_2
e_1_3_1_15_2
e_1_3_1_5_2
e_1_3_1_14_2
e_1_3_1_2_2
e_1_3_1_19_2
e_1_3_1_18_2
References_xml – ident: e_1_3_1_22_2
  doi: 10.1002/ana.410440726
– ident: e_1_3_1_20_2
  doi: 10.1016/0165-0173(94)00014-G
– ident: e_1_3_1_18_2
  doi: 10.1111/j.1528-1157.1996.tb01031.x
– ident: e_1_3_1_7_2
  doi: 10.1002/ana.410390505
– ident: e_1_3_1_19_2
  doi: 10.1016/S0920-1211(96)01005-4
– ident: e_1_3_1_12_2
  doi: 10.1016/0022-3956(75)90026-6
– ident: e_1_3_1_2_2
  doi: 10.1016/0166-2236(89)90074-X
– ident: e_1_3_1_13_2
  doi: 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D
– ident: e_1_3_1_14_2
– ident: e_1_3_1_17_2
  doi: 10.1161/01.STR.29.11.2357
– ident: e_1_3_1_5_2
  doi: 10.1523/JNEUROSCI.14-11-07192.1994
– ident: e_1_3_1_8_2
  doi: 10.1007/BF02740748
– ident: e_1_3_1_16_2
  doi: 10.1093/brain/114.5.2095
– ident: e_1_3_1_10_2
  doi: 10.1002/mds.870110310
– ident: e_1_3_1_15_2
– ident: e_1_3_1_4_2
  doi: 10.1126/science.2402638
– ident: e_1_3_1_6_2
  doi: 10.1002/ana.410350605
– ident: e_1_3_1_9_2
  doi: 10.1016/0920-1211(92)90086-9
– ident: e_1_3_1_11_2
  doi: 10.1212/WNL.17.5.427
– ident: e_1_3_1_3_2
  doi: 10.1016/0306-4522(89)90120-6
– ident: e_1_3_1_21_2
  doi: 10.1002/ana.410280411
SSID ssj0015279
Score 1.8335239
SourceID crossref
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 1583
SubjectTerms Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Medical sciences
Neuropharmacology
Pharmacology. Drug treatments
Title A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NS8MwGA5OQQQRP_GbHMTLyGybtM2OQyciOgQVBQ-laRJUdJPNHfTX-6ZJPyY7zIOX0oYmZXna9yN78j4IHTGjGeJFigjwJoRRFhMhfEoCKsDZxjpSPBexvY17j_ysy7qFwDhk_WXbvyINbYC12Tn7B7TLQaEBzgFzOALqcJwJ947lCBrSpRo2wRPJwfvLt5IFKf0NTq1UB4SJQ2XWs99fpGo-f0mjnmUIeXCVGo2cvtudZTmdTkj9tSj3NB5WK_LFsoHhcBK7xbik8XNTWNcaP-WsXxCRiOb65qV5tDWe3WvAa7bOD60EjfObcMmn2mRwjjBpD72rVshavFV1q9e-_uWTSqagyVFggAS6JyFLeGK6N9BCAHbFmLXby175p1EYxO2i6Lb5Za6kKnQ_mXj6RAiy_JGO4GvQVsakFlvcraIVlxTgjkVzDc2p_jpavHa0hw301ME1UHEFKq5AxTmoeKBxBSqeABWnI1wDFQOo-OZsE92fd-9OL4hTxSAZBK-fRKSe1EpBYJnpuO1xoSVkoWEomfJ126OUe4HkkqdCQDKqGZNZGqggozFTMuOabqH5_qCvthGORSqkKciT5qoIvtBUR34kfSEhr6XRDjouJir5sMVPkqmA7KCDiWms7qaUQYaxO-tAe2ipeln30fzncKwOUGMkx4c51j9qKVia
link.rule.ids 315,782,786,27933,27934
linkProvider Multiple Vendors
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+multicenter+randomized+controlled+trial+of+remacemide+hydrochloride+as+monotherapy+for+PD&rft.jtitle=Neurology&rft.date=2000-04-25&rft.issn=0028-3878&rft.eissn=1526-632X&rft.volume=54&rft.issue=8&rft.spage=1583&rft.epage=1588&rft_id=info:doi/10.1212%2FWNL.54.8.1583&rft.externalDBID=n%2Fa&rft.externalDocID=10_1212_WNL_54_8_1583
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-3878&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-3878&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-3878&client=summon